Literature DB >> 8342739

Position paper: Immunotherapy with hymenoptera venoms. (EAACI) The European Academy of Allergology and Clinical Immunology.

.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8342739

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  11 in total

1.  Safety and efficacy of rush allergen-specific immunotherapy in Chinese allergic rhinitis patients.

Authors:  Qianhui Qiu; Mimi Xu; Chuan Lu; Jianjun Chen; Shaohua Chen; Weijia Kong; Hong Han
Journal:  Int J Immunopathol Pharmacol       Date:  2016-08-10       Impact factor: 3.219

2.  Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement.

Authors:  Marek L Kowalski; Ignacio Ansotegui; Werner Aberer; Mona Al-Ahmad; Mubeccel Akdis; Barbara K Ballmer-Weber; Kirsten Beyer; Miguel Blanca; Simon Brown; Chaweewan Bunnag; Arnaldo Capriles Hulett; Mariana Castells; Hiok Hee Chng; Frederic De Blay; Motohiro Ebisawa; Stanley Fineman; David B K Golden; Tari Haahtela; Michael Kaliner; Connie Katelaris; Bee Wah Lee; Joanna Makowska; Ulrich Muller; Joaquim Mullol; John Oppenheimer; Hae-Sim Park; James Parkerson; Giovanni Passalacqua; Ruby Pawankar; Harald Renz; Franziska Rueff; Mario Sanchez-Borges; Joaquin Sastre; Glenis Scadding; Scott Sicherer; Pongsakorn Tantilipikorn; James Tracy; Vera van Kempen; Barbara Bohle; G Walter Canonica; Luis Caraballo; Maximiliano Gomez; Komei Ito; Erika Jensen-Jarolim; Mark Larche; Giovanni Melioli; Lars K Poulsen; Rudolf Valenta; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2016-10-12       Impact factor: 4.084

Review 3.  [Insect venom allergies : Update 2016 for otorhinolaryngologists].

Authors:  L Klimek; N Dippold; A Sperl
Journal:  HNO       Date:  2016-12       Impact factor: 1.284

Review 4.  Fatalities following allergen immunotherapy.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

5.  Role of interleukin 10 in specific immunotherapy.

Authors:  C A Akdis; T Blesken; M Akdis; B Wüthrich; K Blaser
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

Review 6.  Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells.

Authors:  Alison Taylor; Johan Verhagen; Kurt Blaser; Mübeccel Akdis; Cezmi A Akdis
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

7.  Induction of specific immunotherapy with hymenoptera venoms using ultrarush regimen in children: safety and tolerance.

Authors:  Alice Köhli-Wiesner; Lisbeth Stahlberger; Christian Bieli; Tamar Stricker; Roger Lauener
Journal:  J Allergy (Cairo)       Date:  2011-07-19

8.  Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol.

Authors:  Vincenzo Patella; Giovanni Florio; Ada Giuliano; Carmine Oricchio; Giuseppe Spadaro; Gianni Marone; Arturo Genovese
Journal:  J Allergy (Cairo)       Date:  2012-05-24

Review 9.  Hymenoptera Venom Immunotherapy: Immune Mechanisms of Induced Protection and Tolerance.

Authors:  Ajda Demšar Luzar; Peter Korošec; Mitja Košnik; Mihaela Zidarn; Matija Rijavec
Journal:  Cells       Date:  2021-06-22       Impact factor: 6.600

10.  Clinical Features and the Diagnostic Value of Component Allergen-Specific IgE in Hymenoptera Venom Allergy.

Authors:  Yoo Seob Shin; Jing Nan Liu; Gyu-Young Hur; Eui-Kyung Hwang; Young Hee Nam; Hyun Jung Jin; Sang Min Lee; Young-Min Ye; Dong-Ho Nahm; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2012-04-26       Impact factor: 5.764
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.